Exploring The Interplay Between Gut Microbiota And Neurological Disorders: Implications For Therapeutic Interventions
Downloads
Keywords:
Gut microbiota, Neurological disorders, Gut-brain axis, Dysbiosis, Probiotics, Fecal microbiota transplantation, Dietary modifications, Pharmacological interventions, Personalized medicine, Therapeutic interventionsAbstract
The interplay between the gut microbiota and neurological disorders has emerged as a captivating area of research, uncovering intricate connections between the gut and the brain. This comprehensive review explores the role of the gut microbiota in neurological disorders and discusses its implications for therapeutic interventions.
The gut-brain axis serves as a bidirectional communication system, allowing the gut microbiota to influence neurological function. Communication pathways between the gut microbiota and the brain involve immune system modulation, neurotransmitter production and signaling, metabolite production and absorption, and neural connections such as the vagus nerve. Dysbiosis, an imbalance in the gut microbial composition, has been observed in various neurological disorders, including autism spectrum disorders, neurodegenerative diseases, and mood disorders.
Research studies have demonstrated associations between gut dysbiosis and neurological disorders. Animal models have provided insights into the mechanisms underlying the gut microbiota-neurological disorder link, while clinical observations in human populations have supported these findings. The gut microbiota's influence on immune responses, neurotransmitter metabolism, metabolite production, and neural signaling pathways may contribute to the pathogenesis of neurological disorders.
Therapeutic interventions targeting the gut microbiota hold promise for neurological disorders. Probiotics and prebiotics can restore microbial balance and promote a healthy gut microbiota composition. Fecal microbiota transplantation has shown potential in modulating neurological outcomes, although further research is needed. Dietary modifications, such as fiber-rich diets and omega-3 fatty acids, can influence the gut microbiota and improve neurological function. Pharmacological interventions, including antibiotics and targeted compounds, may also modulate the gut microbiota for therapeutic benefit.
Challenges in gut microbiota research include the complexity and variability of the gut microbiota and the need for rigorous study designs. Ethical considerations and safety concerns, particularly regarding fecal microbiota transplantation, should be carefully addressed. The potential for personalized microbiota-based therapeutics is a promising direction, with tailored interventions based on an individual's gut microbial profile. Emerging research areas and technological advancements offer exciting opportunities for understanding the gut-brain connection and developing innovative interventions.
Downloads
References
Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013 May;36(5):305-12.
https://doi.org/10.1016/j.tins.2013.01.005
PMid:23384445
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016 Jun 16;167(4):915-32.
https://doi.org/10.1016/j.cell.2016.10.027
PMid:27814521 PMCid:PMC5127403
Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015 Jun;63:1-9.
https://doi.org/10.1016/j.jpsychires.2015.02.021
PMid:25772005
Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701-12.
https://doi.org/10.1038/nrn3346
PMid:22968153
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013 Dec 19;155(7):1451-63.
https://doi.org/10.1016/j.cell.2013.11.024
PMid:24315484 PMCid:PMC3897394
Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014 Nov 12;34(46):15490-6.
https://doi.org/10.1523/JNEUROSCI.3299-14.2014
PMid:25392516 PMCid:PMC4228144
Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 2016 Dec 1;167(6):1469-80.e12.
https://doi.org/10.1016/j.cell.2016.11.018
PMid:27912057 PMCid:PMC5718049
Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019 Jun 13;177(6):1600-18.e17.
https://doi.org/10.1016/j.cell.2019.05.004
PMid:31150625 PMCid:PMC6993574
Kho ZY, Lal SK. The human gut microbiome--a potential controller of wellness and disease. Front Microbiol. 2018 Jan 16;9:1835.
https://doi.org/10.3389/fmicb.2018.01835
PMid:30154767 PMCid:PMC6102370
Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014 Nov 19;6(263):263ra158.
https://doi.org/10.1126/scitranslmed.3009759
PMid:25411471 PMCid:PMC4396848
Quigley EM. Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep. 2017 Sep;17(9):77.
https://doi.org/10.1007/s11910-017-0802-6
PMid:29039142
Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019 Apr;4(4):623-32.
https://doi.org/10.1038/s41564-018-0337-x
PMid:30718848
Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015 Sep 24;310:561-77.
https://doi.org/10.1016/j.neuroscience.2015.09.033
PMid:26408987
De Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, et al. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun. 2014 Feb;37:197-206.
https://doi.org/10.1016/j.bbi.2013.12.005
PMid:24333160
Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011 Jul;23(12):1132-9.
https://doi.org/10.1111/j.1365-2982.2011.01796.x
PMid:21988661 PMCid:PMC3413724
Zhang Y, Wang L, Zhang J, Li Y, He Q, Li H, et al. Probiotic Lactobacillus casei Zhang ameliorates depression-like behavior in rats with chronic unpredictable mild stress. Nutrients. 2018 May 2;10(5):581.
Liu RT, Walsh RFL, Sheehan AE. Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev. 2019 Jun;102:13-23.
https://doi.org/10.1016/j.neubiorev.2019.03.023
PMid:31004628 PMCid:PMC6584030
Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015 Mar;125(3):926-38.
https://doi.org/10.1172/JCI76304
PMid:25689247 PMCid:PMC4362231
Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017 Jul 26;20(2):145-55.
https://doi.org/10.1038/nn.4476
PMid:28092661 PMCid:PMC6960010
Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci. 2018 May;1420(1):5-25.
https://doi.org/10.1111/nyas.13416
PMid:28768369
Dinan TG, Cryan JF. The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care. 2015 Sep;18(5):552-8.
https://doi.org/10.1097/MCO.0000000000000221
PMid:26372511
Liu Q, Liu S, Chen L, Zhao Z, Du X, Qin Y, et al. Coping with anxiety in Parkinson's disease: a pilot study of a group cognitive-behavioral therapy program. Mov Disord. 2019 Feb;34(2):256-8.
Evrensel A, Ceylan ME. The gut-brain axis: the missing link in depression. Clin Psychopharmacol Neurosci. 2015 Apr 30;13(3):239-44.
https://doi.org/10.9758/cpn.2015.13.3.239
PMid:26598580 PMCid:PMC4662178
Rea K, Dinan TG, Cryan JF. The microbiome: a key regulator of stress and neuroinflammation. Neurobiol Stress. 2016 Nov;4:23-33.
https://doi.org/10.1016/j.ynstr.2016.03.001
PMid:27981187 PMCid:PMC5146205
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5.
https://doi.org/10.1073/pnas.1102999108
PMid:21876150 PMCid:PMC3179073
Nguyen TT, Kosciolek T, Eyler LT, Knight R, Jeste DV. Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. J Psychiatr Res. 2018 Nov;99:50-61.
https://doi.org/10.1016/j.jpsychires.2018.01.013
PMid:29407287 PMCid:PMC5849533
Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, et al. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. Elife. 2016 Jun 28;5:e15092.
https://doi.org/10.7554/eLife.15092
PMid:27253067 PMCid:PMC4915811
Ejtahed HS, Angoorani P, Soroush AR, Atlasi R, Hasani-Ranjbar S, Mortazavian AM, et al. Probiotics supplementation for the obesity management; a systematic review of animal studies and clinical trials. J Funct Foods. 2019 Jun;57:311-20.
https://doi.org/10.1016/j.jff.2018.10.039
Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52.
https://doi.org/10.1073/pnas.1010529108
PMid:21282636 PMCid:PMC3041077
Huang TT, Lai JB, Du YL, Xu Y, Ruan LM, Hu SH. Current understanding of gut microbiota in mood disorders: an update of human studies. Front Genet. 2019 Mar 29;10:98.
https://doi.org/10.3389/fgene.2019.00098
PMid:30838027 PMCid:PMC6389720
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Dr. Michael Sullivan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
License Terms
Ownership and Licensing:
Authors of this research paper submitted to the journal owned and operated by The Science Brigade Group retain the copyright of their work while granting the journal certain rights. Authors maintain ownership of the copyright and have granted the journal a right of first publication. Simultaneously, authors agreed to license their research papers under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License.
License Permissions:
Under the CC BY-NC-SA 4.0 License, others are permitted to share and adapt the work, as long as proper attribution is given to the authors and acknowledgement is made of the initial publication in the Journal. This license allows for the broad dissemination and utilization of research papers.
Additional Distribution Arrangements:
Authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal's published version of the work. This may include posting the work to institutional repositories, publishing it in journals or books, or other forms of dissemination. In such cases, authors are requested to acknowledge the initial publication of the work in this Journal.
Online Posting:
Authors are encouraged to share their work online, including in institutional repositories, disciplinary repositories, or on their personal websites. This permission applies both prior to and during the submission process to the Journal. Online sharing enhances the visibility and accessibility of the research papers.
Responsibility and Liability:
Authors are responsible for ensuring that their research papers do not infringe upon the copyright, privacy, or other rights of any third party. The Science Brigade Publishers disclaim any liability or responsibility for any copyright infringement or violation of third-party rights in the research papers.
Plaudit
License Terms
Ownership and Licensing:
Authors of this research paper submitted to the Journal of Science & Technology retain the copyright of their work while granting the journal certain rights. Authors maintain ownership of the copyright and have granted the journal a right of first publication. Simultaneously, authors agreed to license their research papers under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License.
License Permissions:
Under the CC BY-NC-SA 4.0 License, others are permitted to share and adapt the work, as long as proper attribution is given to the authors and acknowledgement is made of the initial publication in the Journal of Science & Technology. This license allows for the broad dissemination and utilization of research papers.
Additional Distribution Arrangements:
Authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal's published version of the work. This may include posting the work to institutional repositories, publishing it in journals or books, or other forms of dissemination. In such cases, authors are requested to acknowledge the initial publication of the work in the Journal of Science & Technology.
Online Posting:
Authors are encouraged to share their work online, including in institutional repositories, disciplinary repositories, or on their personal websites. This permission applies both prior to and during the submission process to the Journal of Science & Technology. Online sharing enhances the visibility and accessibility of the research papers.
Responsibility and Liability:
Authors are responsible for ensuring that their research papers do not infringe upon the copyright, privacy, or other rights of any third party. The Journal of Science & Technology and The Science Brigade Publishers disclaim any liability or responsibility for any copyright infringement or violation of third-party rights in the research papers.